Healthcare [ 4/11 ] | Drug Manufacturers—Specialty & Generic [ 29/112 ]
US | NASDAQ | Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 8, 23 | 1.17 Increased by +1.07 K% | 0.35 Increased by +669.39% |
| Mar 9, 23 | 0.76 Increased by +40.74% | 0.67 Increased by +20.05% |
| Nov 9, 22 | 0.64 Decreased by -36.63% | 0.55 Increased by +29.75% |
| Aug 8, 22 | 0.13 Decreased by -80.60% | 0.22 Decreased by -185.95% |
| May 10, 22 | -0.12 Decreased by -111.54% | 0.09 Decreased by -2.59 K% |
| Mar 15, 22 | 0.54 Decreased by -32.50% | 0.74 Decreased by -36.52% |
| Nov 1, 21 | 1.01 Increased by +4.12% | 0.70 Increased by +63.27% |
| Aug 6, 21 | 0.67 Decreased by -2.90% | 0.69 Decreased by -4.20% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 23 | 106.79 M Increased by +65.62% | 1.44 M Increased by +107.15% | Increased by +1.35% Increased by +104.32% |
| Dec 31, 22 | 94.23 M Increased by +54.66% | -4.24 M Increased by +91.69% | Decreased by -4.50% Increased by +94.63% |
| Sep 30, 22 | 83.82 M Increased by +61.01% | -8.60 M Decreased by -93.39% | Decreased by -10.26% Decreased by -20.11% |
| Jun 30, 22 | 73.86 M Increased by +51.89% | -14.92 M Decreased by -5.79% | Decreased by -20.21% Increased by +30.35% |
| Mar 31, 22 | 64.48 M Increased by +18.26% | -20.13 M Decreased by -23.51 K% | Decreased by -31.22% Decreased by -19.89 K% |
| Dec 31, 21 | 60.93 M Increased by +6.42% | -51.05 M Decreased by -1.30 K% | Decreased by -83.78% Decreased by -1.22 K% |
| Sep 30, 21 | 52.06 M Decreased by -1.73% | -4.45 M Decreased by -1.12 K% | Decreased by -8.54% Decreased by -1.14 K% |
| Jun 30, 21 | 48.63 M Increased by +0.32% | -14.11 M Decreased by -14.35% | Decreased by -29.01% Decreased by -13.98% |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.